HDAC2: a critical factor in health and disease

被引:129
作者
Kraemer, Oliver H. [1 ]
机构
[1] Univ Jena, CMB, Inst Biochem & Biophys, D-07743 Jena, Germany
关键词
HISTONE DEACETYLASE INHIBITORS; DUCHENNE MUSCULAR-DYSTROPHY; SMOOTH-MUSCLE-CELLS; KAPPA-B ACTIVITY; PML-RAR-ALPHA; VALPROIC ACID; COLON-CANCER; ACETYLATION; EXPRESSION; CHROMATIN;
D O I
10.1016/j.tips.2009.09.007
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Histone deacetylases control cellular signaling and gene expression. Histone deacetylase 2 (HDAC2) is crucial for embryonic development, affects cytokine signaling relevant for immune responses and is often significantly overexpressed in solid tumors. Nevertheless, transformed cells lacking HDAC2 due to somatic mutations have recently been discovered. This finding has raised a question regarding the functions of this enzyme. Detailed analyses of the molecular mechanisms governing gene regulation by HDAC2 illustrate how this protein influences proliferation, apoptosis and differentiation of cells. Beyond clarifying the role of HDAC2 for cellular fate, such data position the epigenetic regulator HDAC2 as a therapeutically important prognostic marker that can be subjected to pharmacological control.
引用
收藏
页码:647 / 655
页数:9
相关论文
共 63 条
[31]   PML-RARα alleviates the transcriptional repression mediated by tumor suppressor Rb [J].
Khan, MM ;
Nomura, T ;
Kim, H ;
Kaul, SC ;
Wadhwa, R ;
Zhong, S ;
Pandolfi, PP ;
Ishi, S .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (47) :43491-43494
[32]   Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors [J].
Khan, Nagma ;
Jeffers, Michael ;
Kumar, Sampath ;
Hackett, Craig ;
Boldog, Ferenc ;
Khramtsov, Nicholai ;
Qian, Xiaozhong ;
Mills, Evan ;
Berghs, Stanny C. ;
Carey, Nessa ;
Finn, Paul W. ;
Collins, Laura S. ;
Tumber, Anthony ;
Ritchie, James W. ;
Jensen, Peter Buhl ;
Lichenstein, Henri S. ;
Sehested, Maxwell .
BIOCHEMICAL JOURNAL, 2008, 409 :581-589
[33]   Requirement of histone deacetylase activity for signaling by STAT1 [J].
Klampfer, L ;
Huang, J ;
Swaby, LA ;
Augenlicht, L .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (29) :30358-30368
[34]   HDAC2 deacetylates class II transactivator and suppresses its activity in macrophages and smooth muscle cells [J].
Kong, Xiaocen ;
Fang, Mingming ;
Li, Ping ;
Fang, Fei ;
Xu, Yong .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2009, 46 (03) :292-299
[35]   Histone deacetylase inhibitors and hydroxyurea modulate the cell cycle and cooperatively induce apoptosis [J].
Kraemer, O. H. ;
Knauer, S. K. ;
Zimmermann, D. ;
Stauber, R. H. ;
Heinzel, T. .
ONCOGENE, 2008, 27 (06) :732-740
[36]   Mechanism for ubiquitylation of the leukemia fusion proteins AML1-ETO and PML-RARα [J].
Kraemer, Oliver H. ;
Mueller, Sylvia ;
Reichardt, Sigrid ;
Heinzel, Thorsten .
FASEB JOURNAL, 2008, 22 (05) :1369-1379
[37]   A phosphorylation-acetylation switch regulates STAT1 signaling [J].
Kraemer, Oliver H. ;
Knauer, Shirley K. ;
Greiner, Georg ;
Jandt, Enrico ;
Reichardt, Sigrid ;
Guehrs, Karl-Heinz ;
Stauber, Roland H. ;
Boehmer, Frank D. ;
Heinzel, Thorsten .
GENES & DEVELOPMENT, 2009, 23 (02) :223-235
[38]   Acetylation of Stat1 modulates NF-κB activity [J].
Krämer, OH ;
Baus, D ;
Knauer, SK ;
Stein, S ;
Jäger, E ;
Stauber, RH ;
Grez, M ;
Pfitzner, E ;
Heinzel, T .
GENES & DEVELOPMENT, 2006, 20 (04) :473-485
[39]   The histone deacetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2 [J].
Krämer, OH ;
Zhu, P ;
Ostendorff, HP ;
Golebiewski, M ;
Tiefenbach, J ;
Peters, MA ;
Brill, B ;
Groner, B ;
Bach, I ;
Heinzel, T ;
Göttlicher, M .
EMBO JOURNAL, 2003, 22 (13) :3411-3420
[40]   HDAC2 regulates chromatin plasticity and enhances DNA vulnerability [J].
Marchion, Douglas C. ;
Bicaku, Elona ;
Turner, Joel G. ;
Schmitt, Morgen L. ;
Morelli, Dawn R. ;
Munster, Pamela N. .
MOLECULAR CANCER THERAPEUTICS, 2009, 8 (04) :794-801